How Arintra Built a 100% Pilot Success Rate By Leading with ROI in Autonomous Medical Coding

Why the Wedge Isn't a Product Decision — It's a GTM Decision

Most B2B founders choose a wedge based on where they can win technically. Arintra's wedge — autonomous medical coding — is interesting because the GTM logic is as important as the technical one.

Medical coding is the process that converts clinical documentation into the standardized codes that form the basis of every insurance claim. Without it, the claim never goes out. Hospitals don't get paid. It is, as Nitesh puts it, "a mandatory workflow in US healthcare."

That single characteristic changes the entire sales motion. Arintra isn't asking health systems to add a new capability or optimize an existing one. They're offering to take over a process that was going to run regardless — and run it better. The question in every sales conversation isn't whether to solve this; it's how and with whom.

This is a different posture than most enterprise SaaS. When your product is attached to a mandatory workflow, you're not creating demand — you're redirecting it. And right now, three forces have made that redirection urgent: the country isn't producing enough trained coders to meet demand, payer-side complexity keeps growing as regulations evolve, and hospital margins are thin enough that revenue cycle inefficiency directly threatens financial stability.

"You cannot just throw in more and more people," Nitesh said. "It will not get solved."

Listen to the full podcast episode here

‍